by Jones Day's PTAB Team | Sep 21, 2017 | Request for Reconsideration
By J. Jason Williams and J. Patrick Elsevier, Ph.D. In Coalition For Affordable Drugs VI, LLC v. Celgene Corp. (2015-01096, -01102, -01103),[1] the PTAB granted Patent Owner Celgene’s request for rehearing of a final written decision that had found the challenged...
by Jones Day's PTAB Team | Jul 25, 2017 | Final Written Decisions, PTAB News
By Christian Damon The ITC recently continued its trend of giving little deference to parallel PTAB IPR proceedings. In Certain Network Devices, Related Software and Components Thereof (II), Inv. No. 337-TA-945, the ITC denied a request to suspend or rescind a...
by Jones Day's PTAB Team | Jul 18, 2017 | PTAB Trial Basics
By John Evans Ph.D. and John Froemming In the wake of the high-profile dispute in Apple v. Samsung, design patent procurement and enforcement activity has increased significantly. But practitioners may not appreciate that design patent validity can be attacked using...
by Jones Day's PTAB Team | Jul 7, 2017 | Pharmaceutical
By Dominic J. Yee, Ph.D. and J. Patrick Elsevier, Ph.D. In a final written decision in Bass, et al., v. Fresenius Kabi USA, LLC (IPR2016-00254), the PTAB found that the challenged claims of Fresenius’s U.S. Patent No. 8,476,010, directed to a sterile pharmaceutical...
by Jones Day's PTAB Team | May 16, 2017 | Federal Circuit Appeal, PTAB News
By Greg Castanias, Sasha Mayergoyz, and Stuart Yothers On May 11, 2017, with six of its twelve active judges authoring or joining separate opinions, the Federal Circuit denied a petition for an initial hearing en banc which asked the full Court to address the question...
